Effect of 5alpha reduced androgens on sex accessory organs, initiation and maintenance of spermatogenesis in the rat.
D000728:Androgens / Q000494:pharmacology*; D015113:Androstane-3,17-diol / Q000494:pharmacology; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D013196:Dihydrotestosterone / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology; D005837:Genitalia, Male / Q000187:drug effects* / Q000254:growth & development; D006065:Gonadotropins, Pituitary / Q000037:antagonists & inhibitors; D007016:Hypophysectomy; D008297:Male; D009929:Organ Size / Q000187:drug effects; D011467:Prostate / Q000187:drug effects; D051381:Rats; D012669:Seminal Vesicles / Q000187:drug effects; D012671:Seminiferous Tubules / Q000187:drug effects / Q000254:growth & development; D012708:Sertoli Cells / Q000648:ultrastructure; D013091:Spermatogenesis / Q000187:drug effects*; D013737:Testis / Q000187:drug effects / Q000254:growth & development; D013739:Testosterone / Q000494:pharmacology
D000728:Androgens; D004967:Estrogens; D006065:Gonadotropins, Pituitary; D013196:Dihydrotestosterone; D015113:Androstane-3,17-diol; D013739:Testosterone